ABSSSI

Related by string. * * Skin Structure Infections ABSSSI . structure infections ABSSSI *

Related by context. Frequent words. (Click for all words.) 64 chronic HCV infection 63 Traficet EN 63 phase IIb clinical 62 Cethromycin 62 superficial bladder cancer 62 daptomycin 61 Hepatitis C HCV 61 chronic HBV infection 60 AA amyloidosis 60 chronic HCV 60 metastatic hormone refractory 60 S. aureus infections 60 nitazoxanide 60 Phase Ib clinical 60 mRCC 59 Hepatitis C Virus HCV 59 Pegasys ® 59 heavily pretreated 59 Hepatitis C virus HCV 59 amphotericin B 59 phase IIa 59 NOXAFIL 59 relapsed multiple myeloma 59 StemEx 59 Phase Ib 59 PREZISTA r 58 elotuzumab 58 Cethrin 58 Epratuzumab 58 INTELENCE 58 GSK# [001] 58 lupus nephritis 58 T#I mutation 58 relapsed refractory multiple myeloma 58 HCV infected 58 idiopathic pulmonary fibrosis IPF 58 ZOSTAVAX 58 OncoVEX GM CSF 58 hepatitis C HCV 58 RRMS patients 58 atherothrombosis 58 liposomal formulation 58 double blinded placebo 58 indolent NHL 57 acute myelogenous leukemia AML 57 ISTODAX 57 ponatinib 57 CR# vcMMAE 57 Phenoptin 57 systemic lupus erythematosus SLE 57 HSCT 57 ATL# [001] 57 iclaprim 57 HCV infection 57 P. aeruginosa 57 liver transplant recipients 57 isavuconazole 57 Voreloxin 57 sustained virologic response 57 tipranavir 57 Amigal 57 anti TNF alpha 57 R sorafenib tablets 57 cangrelor 57 talabostat 57 Phase 2a trial 57 Irinotecan 57 secondary hyperparathyroidism 57 decitabine 57 romidepsin 57 Alemtuzumab 57 pancreatic insufficiency 56 Gemzar ® 56 dasatinib 56 Phase 1b clinical 56 daunorubicin 56 registrational 56 Dengue virus 56 celgosivir 56 HCV genotype 1 56 active comparator 56 lipid lowering therapy 56 methylnaltrexone 56 Phase Ia 56 patients undergoing percutaneous 56 pneumoniae 56 Azedra 56 pseudobulbar affect PBA 56 Hypoactive Sexual Desire Disorder 56 nilotinib 56 Amrubicin 56 Chlamydia trachomatis 56 Zolinza 56 pheochromocytoma 56 Combination therapy 56 immunocompromised patients 56 mTOR inhibitor 56 bone metastasis 56 prospective multicenter 56 Mipomersen 56 pertuzumab

Back to home page